Gilman Hill Asset Management’s Calumet Specialty Products CLMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-21,590
Closed -$86K 163
2016
Q4
$86K Hold
21,590
0.03% 184
2016
Q3
$97K Hold
21,590
0.04% 188
2016
Q2
$106K Sell
21,590
-75
-0.3% -$425 0.04% 180
2016
Q1
$255K Buy
+21,665
New +$301K 0.12% 140
2015
Q4
Sell
-8,915
Closed -$216K 178
2015
Q3
$216K Sell
8,915
-6,500
-42% -$169K 0.11% 142
2015
Q2
$392K Sell
15,415
-750
-5% -$19.9K 0.19% 107
2015
Q1
$389K Buy
16,165
+5,986
+59% +$151K 0.18% 104
2014
Q4
$228K Buy
10,179
+2,487
+32% +$64.7K 0.12% 139
2014
Q3
$211K Hold
7,692
0.11% 142
2014
Q2
$245K Buy
+7,692
New +$229K 0.13% 131

Other funds holding CLMT

Gilman Hill Asset Management's CLMT Position: Q1 2017 in Review

Gilman Hill Asset Management sold out of Calumet Specialty Products (CLMT) in Q1 2017, closing a stake of 21,590 shares — an estimated $86K sold.

Gilman Hill Asset Management first reported a position in CLMT in Q2 2014 and held it in 10 quarters. The position peaked at $392K in Q2 2015. 68 funds tracked by Wall St. Rank hold CLMT as of Q1 2017.

  • Gilman Hill Asset Management reported no remaining Calumet Specialty Products position as of Q1 2017 after selling out during the quarter.
  • Gilman Hill Asset Management sold 21,590 Calumet Specialty Products shares in Q1 2017, an estimated $86K.
  • Gilman Hill Asset Management first reported a position in Calumet Specialty Products in Q2 2014 and held it in 10 quarters.
  • Gilman Hill Asset Management's Calumet Specialty Products position peaked at $392K in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Calumet Specialty Products as of Q1 2017.

Based on Gilman Hill Asset Management's 13F filing for Q1 2017, filed 24 Apr 2017.